243293 Physician Clinical Support System for Methadone: Preliminary quantitative evaluation results

Tuesday, November 1, 2011

Jonathon Gass Jr., MPH , Center for Evaluation and Applied Research (CEAR), The New York Academy of Medicine, New York, NY
James E. Egan, MPH , Center for Urban Epidemiologic Studies (CUES), The New York Academy of Medicine, New York, NY
David Fiellin, MD , Yale University School of Medicine, New Haven, CT
Tracy Gartenmann, BA , Strategic Partnerships and Product Development (SPPD), American Society of Addiction Medicine (ASAM), Chevy Chase, MD
Karen Miotto, MD , Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA
Linda Weiss, PhD , Center for Evaluation and Applied Research, The New York Academy of Medicine, New York, NY
Andrew Saxon, MD , Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA
The Physician Clinical Support System for Methadone (PCSS-M) is a free, nationwide SAMHSA/CSAT-funded program through which health care providers seeking information and mentoring on the use of methadone for the treatment f opioid addiction and/or pain can be connected to experts in the field. PCSS-M provides access to a network of physician mentors with expertise in the use of methadone in an effort to increase the appropriate use and safety of this efficacious but clinically challenging medication. The mean age of mentors is 50 (range 39-65); 31% are female; 100% identify as white. Mentors reported an average of 14 years experience treating either chronic pain or opioid dependence with methadone. Between September 2009 and February 2011, a total of 392 individuals have registered into the PCSS-M from 35 states and Canada. Those registered identified their specialty as General Internal Medicine (52%), Psychiatry (19%), Addiction Medicine (14%), Pain Management (4%), among others. A total of 75 contacts with 53 participants have been logged into the web-based system for tracking mentoring services. Seventy-two percent of all contacts were related to opioid dependence treatment with methadone and predominantly concerned patient assessment, medication management, and urine toxicology mentoring. Of all contacts related to pain treatment with methadone, 34% concerned patient assessment, 22% concerned pain, 29% concerned medication management, and 15% concerned urine toxicology. The majority (89%) of contacts were routine/non-urgent communication. Qualitative data show that the PCSS-M is a valued training tool for health professionals. Efforts to expand the use of PCSS-M are warranted.

Learning Areas:
Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Describe preliminary quantitative evaluation results from PCSS-M, an online mentoring program that aims to increase the appropriate use and safety of methadone treatment for opioid addiction and/or pain.

Keywords: Methadone Maintenance, Education

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am Senior Project Coordinator at the New York Academy of Medicine. I have four years of experience evaluating substance use-related projects and I am the Evaluation Coordinator of the PCSS-Methadone system.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.